Aptevo Therapeutics (APVO) Work In Process (2015 - 2019)
Aptevo Therapeutics (APVO) posted Work In Process of $2.0 million for Q4 2019, down 64.2% sequentially from $5.5 million in Q3 2019, and up 113.76% YoY from $916000.0 in Q4 2018.
Aptevo Therapeutics (APVO) Work In Process (2015 - 2019) Analysis & Trends
Aptevo Therapeutics has reported Work In Process for 5 years, with the latest figure at $2.0 million in Q4 2019.
- Quarterly Work In Process rose 113.76% year-over-year to $2.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $2.0 million (up 113.76% YoY) and the FY2019 annual result came in at $2.0 million, up 113.76% from the prior year.
- Work In Process eased to $2.0 million in Q4 2019 per APVO's latest filing, from $5.5 million in the prior quarter.
- Over five years, Work In Process peaked at $5.9 million in Q2 2019 and troughed at $4000.0 in Q4 2016.
- A 5-year average of $2.5 million and a median of $1.8 million in 2016 frame the typical range for Work In Process.
- The sharpest annual moves came in 2016 and 2017: Work In Process plunged 99.92% in 2016, then soared 11950.0% in 2017.
- Over 5 years, Work In Process stood at $4.7 million in 2015, then slumped by 99.92% to $4000.0 in 2016, then jumped by 11950.0% to $482000.0 in 2017, then jumped by 90.04% to $916000.0 in 2018, then soared by 113.76% to $2.0 million in 2019.
- According to Business Quant data, Work In Process over the past three periods registered $2.0 million, $5.5 million, and $5.9 million for Q4 2019, Q3 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.41 Bn | 130.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.41 Bn | 59.23 Bn | 1.37 Bn |
| 4 | Moderna | 57.56 Bn | 52.43 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.06 Bn | 36.96 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.95 Bn | 27.65 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.48 Bn | 9.09 Bn | 668.28 Mn |
| 8 | Insmed | 27.31 Bn | 26.15 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.04 Bn | 26.20 Bn | - |
| 10 | Aptevo Therapeutics | 3.30 Mn | -6.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 1.96 Mn |
| Sep 30, 2019 | 5.47 Mn |
| Jun 30, 2019 | 5.86 Mn |
| Mar 31, 2019 | 4.02 Mn |
| Dec 31, 2018 | 916,000.00 |
| Sep 30, 2018 | 2.46 Mn |
| Jun 30, 2018 | 2.86 Mn |
| Mar 31, 2018 | 658,000.00 |
| Dec 31, 2017 | 482,000.00 |
| Sep 30, 2017 | 57,000.00 |
| Jun 30, 2017 | 1.64 Mn |
| Mar 31, 2017 | 1.57 Mn |
| Dec 31, 2016 | 4,000.00 |
| Sep 30, 2016 | 1.65 Mn |
| Jun 30, 2016 | 5.15 Mn |
| Dec 31, 2015 | 4.73 Mn |